"Driving Growth in the Peptide and Oligonucleotide CDMO Market: Key Insights for 2025-2031"
The growing focus on precision medicine has had a profound impact on the peptide and oligonucleotide industry. With advancements in genomics and biotechnology, these compounds are increasingly being used in targeted therapies. As pharmaceutical companies continue to embrace personalized medicine, the demand for CDMOs that can provide tailored manufacturing solutions for peptides and...
0 Comments
0 Shares
156 Views